119 related articles for article (PubMed ID: 2146085)
21. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
Fritzberg AR; Kasina S; Eshima D; Johnson DL
J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
[TBL] [Abstract][Full Text] [Related]
23. Handling of 99mTc-MAG3 in the kidney.
Müller-Suur C; Müller-Suur R
Contrib Nephrol; 1990; 79():17-20. PubMed ID: 2146082
[No Abstract] [Full Text] [Related]
24. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?
Dubovsky EV; Russell CD; Yester MV; Thorstad BL; Ryan JP
Contrib Nephrol; 1990; 79():118-22. PubMed ID: 2146081
[No Abstract] [Full Text] [Related]
25. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
[TBL] [Abstract][Full Text] [Related]
26. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T
Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
[TBL] [Abstract][Full Text] [Related]
27. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
Müller-Suur R; Bois-Svensson I; Mesko L
J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
[TBL] [Abstract][Full Text] [Related]
28. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
[TBL] [Abstract][Full Text] [Related]
29. 99mTc-MAG3: chemistry and biokinetics of by-products.
Brandau W; Bubeck B; Schober O; Weber E; Taylor DM
Contrib Nephrol; 1990; 79():11-6. PubMed ID: 2146079
[No Abstract] [Full Text] [Related]
30. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
[TBL] [Abstract][Full Text] [Related]
31. Effect of advanced age on p-aminohippurate-induced inhibition of renal tubular secretion in male Fischer 344 rats.
Galinsky RE; Eshima D; Hansen L; Greene J; Dillehay D; Taylor A
Mech Ageing Dev; 1990 Dec; 56(3):209-22. PubMed ID: 2150974
[TBL] [Abstract][Full Text] [Related]
32. Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moieties.
Vanbilloen HP; De Roo MJ; Verbruggen AM
Eur J Nucl Med; 1996 Jan; 23(1):40-8. PubMed ID: 8586100
[TBL] [Abstract][Full Text] [Related]
33. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
[TBL] [Abstract][Full Text] [Related]
35. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
36. Radionuclide renal studies.
Abdel-Dayem HM; Turoglu HT
Curr Opin Radiol; 1990 Dec; 2(6):834-43. PubMed ID: 2149277
[No Abstract] [Full Text] [Related]
37. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension.
Lee HB; Blaufox MD
J Nucl Med; 1989 May; 30(5):666-71. PubMed ID: 2523959
[TBL] [Abstract][Full Text] [Related]
38. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
Bagni B; Portaluppi F; Montanari L; Prandini N; Zatta G
J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
[TBL] [Abstract][Full Text] [Related]
39. Renal parenchymal transit time of 99mTc-MAG3 from factor analysis and from region-of-interest selection in hydronephrosis.
Russell CD; Yester MV; Dubovsky EV
Contrib Nephrol; 1990; 79():68-71. PubMed ID: 2146088
[No Abstract] [Full Text] [Related]
40. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
Taylor A; Eshima D; Christian PE; Milton W
Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
